Trinity Biotech Plc (TRIB)
0.9499
-0.12
(-11.22%)
USD |
NASDAQ |
Dec 15, 16:00
0.9499
0.00 (0.00%)
After-Hours: 19:05
Trinity Biotech Research and Development Expense (TTM): 4.560M for March 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amarin Corp. Plc | 17.36M |
| DBV Technologies SA | 95.77M |
| Cellectis SA | 70.72M |
| Akari Therapeutics Plc | 2.971M |
| Biodexa Pharmaceuticals Plc | 6.352M |